RecruitingNCT04959097
RB Liquid Biopsy Biorepository
Retinoblastoma Patient Clinical Database, Liquid Biopsy and Tissue Biorepository
Sponsor
Children's Hospital Los Angeles
Enrollment
800 participants
Start Date
Jan 1, 2017
Study Type
OBSERVATIONAL
Conditions
Summary
Retinoblastoma (RB) is a primary eye cancer that forms in the back of the eye of infants and toddlers. Traditionally, RB is diagnosed without a biopsy; tumor can only be studied once an eye has been surgically removed. Given this limitation, we use aqueous humor (AH), the clear fluid in the front of the eye to detect specific markers, or information, that comes from the tumor itself.
Eligibility
Min Age: 0 YearsMax Age: 18 Years
Inclusion Criteria1
- All patients, age 0 days to 18 years, with a diagnosis unilateral or bilateral retinoblastoma (RB) seen at CHLA (Children's Hospital Los Angeles).
Exclusion Criteria1
- Patients referred for second opinions only and not treated at CHLA for any reason.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04959097
Related Trials
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
NCT011093945 locations
Detailed Phenotypic and Genotype Study to Correlate RB1 Mutations Relating to Primary Ocular Tumors and Secondary Extra-ocular Metastasis.
NCT067251731 location
Therapeutic Recommendations For The Treatment Of Children With A Retinoblastoma
NCT044254347 locations
Can Pretreatment MRI be Used to Predict Intra-arterial Chemotherapy Response in Retinoblastoma?
NCT032674591 location
Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual Outcome
NCT0468141728 locations